Table 2.

Mean BSCVA at Each Study Visit and Change in Vision Over Each Time Interval, Shown Separately for the Complete Case Analysis and the Multiple Imputation Analysis

Study Visit	BSCVA: Complete Case,N= 47		BSCVA: Multiple Imputation,N= 75
	Mean logMAR (Snellen), 95% CI*	PValue†	Mean logMAR (Snellen), 95% CI*	PValue†
Enrollment	0.85 (20/160), 0.71–0.99	–	0.97 (20/200), 0.85–1.09	–
3 wks	0.56 (20/80), 0.44–0.68	<0.001	0.63 (20/100), 0.52–0.74	<0.001
3 mo	0.43 (20/63), 0.31–0.56	0.002	0.50 (20/63), 0.38–0.62	0.001
12 mo	0.36 (20/50), 0.25–0.47	0.01	0.45 (20/63), 0.32–0.59	0.31
4 y	0.36 (20/50), 0.25–0.46	0.88	0.45 (20/63), 0.20–0.70	0.99

^*Mean logMAR BSCVA predicted from the repeated measures model, with Snellen equivalent in parentheses, followed by 95% CIs of the logMAR BSCVA.

^†Wald test of the hypothesis that BSCVA is the same as that of the previous study visit, as assessed from the repeated measures model.